Muscular Dystrophy Clinical Trials

A listing of Muscular Dystrophy medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.

Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 17790 clinical trials
Featured trial
Interactive Effects of Periodontitis, the Gut Microbiome, and ApoE4 in Alzheimer’s Disease

This study is looking for people over the age of 65. The study is interested in the possible relationship between gum disease, gut health, and cognition.

Accepts healthy volunteers
  • 135 views
  • 28 Feb, 2022
  • 1 location
Featured trial
Multi-center, double-blind, double-dummy, randomized, placebo- and active-reference, parallel group, Phase 2 dose-finding study with ACT-132577 in subjects with essential hypertension (grade 1 and 2)

Multi-center, double-blind, double-dummy, randomized, placebo- and active-reference, parallel group, Phase 2 dose-finding study with ACT-132577 in subjects with essential hypertension (grade 1 and 2)

  • 468 views
  • 08 Nov, 2020
  • 1 location
Featured trial
A long-term 4+ year, double blind placebo controlled study to evaluate the effects of bexagliflozin on hemoglobin A1c in patients with type 2 diabetes and increased risk of cardiovascular adverse events

A long-term 4+ year, double blind placebo controlled study to evaluate the effects of bexagliflozin on hemoglobin A1c in patients with type 2 diabetes and increased risk of cardiovascular adverse events

  • 342 views
  • 08 Nov, 2020
  • 1 location
Featured trial
Determining correlation of altered heart rate regulation and reduced glymphatic clearance in Alzheimer disease

This study is looking for people who have early Alzheimer’s. The study is interested in the relationship between heart health and brain health in Alzheimer’s.

  • 0 views
  • 24 Mar, 2022
  • 1 location
Featured trial
Autoimmune Features of Neurodegenerative Disorders

This study is looking for people over the age of 55 who have Alzheimer’s. The study is also looking for people who do not have Alzheimer’s, as a comparison. The study is interested in the relationship between cognition, health history, and immune factors.

dementia
cognitive impairment
mild cognitive impairment
Accepts healthy volunteers
  • 0 views
  • 24 Jan, 2022
  • 1 location
Featured trial
BRIDGE: Bridging Anticoagulation in Patients who Require Temporary Interruption of Warfarin Therapy for an Elective Invasive Procedure or Surgery

BRIDGE: Bridging Anticoagulation in Patients who Require Temporary Interruption of Warfarin Therapy for an Elective Invasive Procedure or Surgery

  • 92 views
  • 25 Mar, 2021
  • 1 location
Featured trial
Memory Education and Research Initiative (MERI)

The MERI program began in 2003 under the direction of Nunzio Pomara, MD and was developed  to offer memory and cognitive evaluations to members of the community at no cost. This

alzheimer's disease
  • 292 views
  • 11 Nov, 2021
  • 1 location
Featured trial
A Crossover Study Evaluating 3 Non-medicated Silicone Intravaginal Rings

This is a study evaluating 3 non-medicated silicone vaginal rings. The primary aim of this study is to find out which ring size women like best and if male partners prefer one ring size over another. We want to know if the size of the ring makes a difference in …

Accepts healthy volunteers
  • 14 views
  • 05 Apr, 2022
  • 1 location
Featured trial
Study of Ruxolitinib Cream in Children With Atopic Dermatitis

Open-label, BID application to all affected areas identified at BSLN for 4 weeks (maximum use trial (MUsT) period). The next 4 weeks (treatment extension period) will be applied BID to active lesions only for the next 4 weeks for a total treatment period of 8 weeks. Eligible participants will be …

  • 0 views
  • 21 Mar, 2022
  • 16 locations
Featured trial
A clinical trial to evaluate the safety of NLRP3i (inhibitor of a protein called NLRP3) and how it affects the body and brain of people living with early-stage Parkinson’s disease.

This is a Phase 1b study conducted in the US, the UK, and the Netherlands and aiming to better understand the safety of an oral drug in a capsule form which includes a substance called NLRP3 inhibitor. The study aims to understand how the NLRP3 inhibitor affects the body and …

alpha-synuclein
brain stimulation
dementia
cancer
levodopa
  • 0 views
  • 16 Jun, 2022
  • 15 locations